Immunization practices in children with a history of allergies

Hatice Ezgi Barış1, Perran Boran1, Ayça Kıykım2

  • 1Division of Social Pediatrics, Department of Pediatrics, Marmara University Faculty of Medicine, İstanbul, Turkey.

Turk Pediatri Arsivi
|October 16, 2020
PubMed

Insights

Egg allergy often prevents childhood vaccinations, leading to delays. This study found no adverse reactions in children vaccinated for measles-mumps-rubella (MMR) in a hospital setting, supporting primary care administration.

Area of Science:

  • Pediatric Allergy and Immunology
  • Vaccinology
  • Public Health

Background:

  • Food allergies, particularly egg allergy, cause primary physicians to defer vaccinations.
  • Children with allergy concerns are often referred to hospital settings for vaccine administration.
  • This practice can lead to significant delays in adhering to national immunization schedules.

Purpose of the Study:

  • To evaluate children referred to a university hospital's Well Child Clinic due to allergy concerns.
  • To assess the safety and outcomes of vaccine administration in this high-risk pediatric population.
  • To identify barriers to timely vaccination in children with suspected food allergies.

Main Methods:

  • Retrospective chart review of 122 children referred for allergy concerns over two years.
  • Data collected included demographics, allergy history, laboratory evaluations, and post-vaccination reactions.
  • Specific focus on reactions to egg, other foods, and previous vaccinations.

Main Results:

  • Egg allergy was the most frequent referral reason (43.5%), followed by multiple food reactions (36.5%).
  • Sensitization to egg white (54.1%) and yolk (20.5%) was confirmed in a significant portion of children.
  • Despite referrals, no significant adverse reactions were observed post-vaccination, except for one case of mild rash.

Conclusions:

  • Egg allergy is a major, often unfounded, barrier to vaccine administration by primary care physicians.
  • The measles-mumps-rubella (MMR) vaccine can be safely administered in primary care settings for children with allergy concerns.
  • Reinstating MMR vaccine administration in primary care can prevent delays in the national immunization schedule.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
50.2K
Allergic Reactions02:06

Allergic Reactions

Overview
31.1K
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
5.1K
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
14.5K
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.2K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
606